Cipher Pharmaceuticals(FRA) PHE

Market Cap€213.49M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€8.15

-2.98%

-0.25Today

Cipher Pharmaceuticals Financials at a Glance

Market Cap

€213.49M

Revenue (TTM)

€42.55

Net Income (TTM)

€24.86

EPS (TTM)

€0.96

P/E Ratio

8.55

Dividend

€0.00

Beta (Volatility)

-0.03 (Low)

Dividend

€0.00

Beta (Volatility)

-0.03 (Low)

Price

€8.15

Volume

Open

€8.15

Price

€8.15

Volume

Open

€8.15

Previous Close

€8.40

Daily Range

€8.15 - €8.15

52-Week Range

€7.00 - €12.20

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.03 (Low)

Price

€8.15

Volume

Open

€8.15

Previous Close

€8.40

Daily Range

€8.15 - €8.15

52-Week Range

€7.00 - €12.20

Estimated Earnings Date

N/A

PHE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cipher Pharmaceuticals

Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Mississauga, Canada.

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Craig Mull

Website

www.cipherpharma.com

PHE Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

23.31%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

11.70%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€213.49M

Shares Outstanding

25.42M

Volume

Avg. Volume

11.364

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Cipher Pharmaceuticals Performance Analysis

Cipher Pharmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 19,672,222	6.0%
2023	2023-12-31	EUR 19,574,225	-0.5%
2024	2024-12-31	EUR 30,843,381	57.6%
2025	2025-12-31	EUR 44,703,159	44.9%

Cipher Pharmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 0.98	301.6%
2023	2023-12-31	EUR 0.74	-24.5%
2024	2024-12-31	EUR 0.42	-42.9%
2025	2025-12-31	EUR 0.93	120.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€10.38

+0.9%

Gross Profit

€6.81

+0.9%

Gross Margin

65.58%

+1.0%

Market Cap

€213.49M

N/A

Market Cap/Employee

€5.67

N/A

Employees

N/A

Net Income

€3.45

+0.7%

EBITDA

€5.38

+0.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€8.29

-73.6%

Total Debt

€0.32

+0.0%

Accounts Receivable

€10.62

+1.1%

Inventory

€8.08

+1.7%

Long Term Debt

€0.11

+0.0%

Short Term Debt

€0.21

+0.9%

Return on Assets

18.62%

+1.8%

Return on Invested Capital

23.23%

+1.1%

Free Cash Flow

€2.60

+0.5%

Operating Cash Flow

€2.62

+0.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

INTCIntel

INTCIntel$89.51+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$25.32+0.06%

NVDANvidia

NVDANvidia$220.78+0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$143.69+0.02%

Questions About PHE

What is the current price of Cipher Pharmaceuticals?

Cipher Pharmaceuticals is trading at €8.15 per share.

What is the 52-week range for Cipher Pharmaceuticals?

Over the past 52 weeks, Cipher Pharmaceuticals has traded between €7.00 and €12.20.

How much debt does Cipher Pharmaceuticals have?

As of the most recent reporting period, Cipher Pharmaceuticals reported total debt of €321.00K.

How much cash does Cipher Pharmaceuticals have on hand?

Cipher Pharmaceuticals reported €7.97M in cash and cash equivalents in its most recent financial results.

What is Cipher Pharmaceuticals’s dividend yield?

Cipher Pharmaceuticals does not currently have a dividend yield.

Cipher Pharmaceuticals(FRA) PHE

Cipher Pharmaceuticals Financials at a Glance

PHE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cipher Pharmaceuticals

PHE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PHE

What is the current price of Cipher Pharmaceuticals?

What is the 52-week range for Cipher Pharmaceuticals?

How much debt does Cipher Pharmaceuticals have?

How much cash does Cipher Pharmaceuticals have on hand?

What is Cipher Pharmaceuticals’s dividend yield?

Premium Investing Services